CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

RBC Lifts Price Target on Contineum Therapeutics to $23 From $22, Keeps Outperform, Speculative Risk

Positive
AI Analysis

Summary

RBC Capital Markets raised its price target on Contineum Therapeutics from $22 to $23 while maintaining an Outperform rating, citing speculative risk considerations.

Importance:2/10
Sentiment:
0.30
price_target_increaseanalyst_noterating_outperform
Related Companies

Read the original article

Published by yahoo_finance on July 31, 2026 12:52 PM

Read Original